1.	Comparative Evaluation of MRI and MDCT for the Detection of Metastic Pulmonary Nodules Phase: Phase III Type: Diagnostic Status: Active Age: 2 to 18 Sponsor: Other Protocol IDs: 1000010635, NCT00751920
2.	Phase II Randomized Study of Dynamic Contrast-Enhanced MRI Assessment of Vascular Changes Induced With Bevacizumab Alone Versus in Combination With Recombinant Interferon Alpha-2a in Patients With Previously Untreated Stage III-IV Renal Cell Carcinoma Phase: Phase II Type: Biomarker/Laboratory analysis, Diagnostic, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: MTVERNHOSP-RD2007-114, RD 2007-114, ENH-RD2007-114, EUDRACT-2008-006414-19, EU-20917, NCT00873236
3.	Diagnostic Study of Fludeoxyglucose F 18 Positron Emission Tomography and Magnetic Resonance Perfusion Imaging to Predict Likelihood of Progression and Potential Benefit of Treatment in Patients With Neurofibromatosis 1 and Plexiform Neurofibromas Phase: No phase specified Type: Diagnostic Status: Active Age: 25 and under Sponsor: Other Protocol IDs: CHP-724, CHP-IRB-2001-8-2543, NCT00060008
4.	Dynamic Breast MRI in Assessing Locally Advanced Breast Cancer Phase: No phase specified Type: Diagnostic, Treatment Status: Active Age: Not specified Sponsor: Other Protocol IDs: 237-2006, NCT00455273
5.	Study of Volume Imaging for Breast Assessment NT (VIBRANT-DE) and 3D Fast Spin-Echo Extended Echo-Train Acquisition (3DFSE-XETA) MRI Sequences for the Diagnosis of Breast Cancer in Women Phase: No phase specified Type: Diagnostic Status: Active Age: Over 21 Sponsor: NCI Protocol IDs: MSKCC-07091, 07-091, NCT00514319
6.	Assessment of Liver Cancer Response to TACE Using MultiHance-Enhanced MRI Phase: No phase specified Type: Diagnostic, Treatment Status: Active Age: 18 to 80 Sponsor: Other Protocol IDs: J06108, NA_00003943, NCT00539253
7.	Magnetic Resonance Spectroscopic Imaging of the Prostate at 3 Tesla Phase: No phase specified Type: Diagnostic Status: Active Age: 21 and over Sponsor: Other Protocol IDs: 06-035, NCT00588679